Collaboration, partnership, and clinical integration are key.
Complete Genomics, a U.S.-based, innovator in genomic sequencing platforms and solutions, today announced it is commencing shipments of DNBSEQ-T7+ high-throughput sequencing platform at the 2026 ...
Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene ...
In the fast-changing landscape of the health and wellness sector, businesses require more than generic solutions. They seek platforms that can evolve in accordance with their distinct vision, branding ...
Every living organism has its own genetic "blueprint": the source code for how it grows, functions and reproduces. This ...
The potential of gene therapy and the advances in sequencing technologies have opened the door to treating and curing diseases such as cancer, cystic fibrosis, and heart conditions. This has led to ...
The knowledge and understanding acquired from genomics research can be applied in a number of different settings, including medicine, biotechnology and social sciences. Although the applications of ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
StockStory.org on MSN
10x Genomics (NASDAQ:TXG) delivers impressive Q4 CY2025
Biotech company 10x Genomics (NASDAQ:TXG) reported in Q4 CY2025, but sales were flat year on year at $166 million. The ...
New Early Access Express License provides streamlined, affordable access to foundational CRISPR/Cas9 intellectual property to early-stage innovatorsDUBLIN and CHESHIRE, England, Feb. 24, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results